Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited

Antoni Ribas; Rajarshi Sengupta; Trevan Locke; Sayyed Kaleem Zaidi; Katie M. Campbell; John M. Carethers; Elizabeth M. Jaffee; E. John Wherry; Jean-Charles Soria; Gypsyamber D'Souza

doi:10.1158/2159-8290.CD-20-1817

Science in Society

Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited

Antoni Ribas, Rajarshi Sengupta, Trevan Locke, Sayyed Kaleem Zaidi, Katie M. Campbell, John M. Carethers, Elizabeth M. Jaffee, E. John Wherry, Jean-Charles Soria and Gypsyamber D'Souza; for the AACR COVID-19 and Cancer Task Force

Antoni Ribas

1Department of Medicine and Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: aribas@mednet.ucla.edu

Rajarshi Sengupta

2American Association for Cancer Research, Philadelphia, Pennsylvania.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Trevan Locke

2American Association for Cancer Research, Philadelphia, Pennsylvania.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sayyed Kaleem Zaidi

2American Association for Cancer Research, Philadelphia, Pennsylvania.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Katie M. Campbell

1Department of Medicine and Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Katie M. Campbell

John M. Carethers

3Departments of Internal Medicine and Human Genetics and Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for John M. Carethers

Elizabeth M. Jaffee

4Department of Medicine, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Elizabeth M. Jaffee

E. John Wherry

5Department of Systems Pharmacology and Translational Therapeutics, Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jean-Charles Soria

6Paris Saclay University, Saint-Aubin, France and Drug Development Department, Gustave Roussy, Villejuif, France.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gypsyamber D'Souza

7Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Gypsyamber D'Souza

DOI: 10.1158/2159-8290.CD-20-1817

Article
Figures & Data
Info & Metrics
PDF

Article Figures & Data

Additional Files

Supplementary Data

Tables S1-S4 - Supplemental Table S1. Studies comparing outcomes among SARS-COV-2 infected patients with cancer and those without cancer. Supplemental Table S2. Studies comparing outcomes among SARS-COV-2 infected patients with cancer and uninfected patients with cancer Supplemental Table S3. Studies reporting outcomes among SARS-COV-2 infected patients with cancer without any comparison Supplemental Table S4. Metanalyses of published studies on COVID-19-cancer connection
AACR COVID-19 and Cancer Task Force - AACR COVID-19 and Cancer Task Force
AACR COVID-19 and Cancer Task Force Bios - AACR COVID-19 and Cancer Task Force Bios

PreviousNext

This OnlineFirst version was published on January 4, 2021
doi: 10.1158/2159-8290.CD-20-1817

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited

Message Subject (Your Name) has forwarded a page to you from Cancer Discovery

Message Body (Your Name) thought you would be interested in this article in Cancer Discovery.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited